A selective Jak1 Inhibitor, Filgotinib (GLPG0634) suppresses lymphocytic infiltration in the salivary gland of non-obese diabetic mice via suppression of BAFF, IP10 and CXCL13 production of salivary gland epithelial cells — ASN Events
  1. Schedule
  2. Poster Session Two
  3. A selective Jak1 Inhibitor, Filgotinib (GLPG0634) suppresses lymphocytic infiltration in the salivary gland of non-obese diabetic mice via suppression of BAFF, IP10 and CXCL13 production of salivary gland epithelial cells

A selective Jak1 Inhibitor, Filgotinib (GLPG0634) suppresses lymphocytic infiltration in the salivary gland of non-obese diabetic mice via suppression of BAFF, IP10 and CXCL13 production of salivary gland epithelial cells (#254)

seungmin Hong 1 , Jaeseon Lee 1 , Jennifer J Lee 2 , Seungki Kwok 2 , Seungye Baek 1 , SeGwang Jang 1 , Mi-La Cho 1 , Sung-Hwan Park 1 2
  1. Rheumatism Research Center, Institute of Biomedical Industry, The Catholic University of Korea, Seoul
  2. Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul
Publish consent withheld
#ASI2017QLD